Results 11 to 20 of about 395,223 (154)

Off-label use of atypical antipsychotics- Where are we?

open access: yesEuropean Psychiatry, 2023
Introduction Nowadays, In the exercise of psychiatric clinical activity, the prescription of atypical antipsychotics is a widespread practice. However, despite the approval in the treatment of psychoses and bipolar affective disorder, where its ...
R. P. Vaz   +9 more
doaj   +1 more source

Association of typical versus atypical antipsychotics with symptoms and quality of life in schizophrenia. [PDF]

open access: yesPLoS ONE, 2012
BACKGROUND: Several reports on patients with chronic schizophrenia suggest that atypical versus typical antipsychotics are expected to lead to better quality of life (QOL) and cognitive function.
Koichiro Fujimaki   +2 more
doaj   +1 more source

Atypicality of Atypical Antipsychotics [PDF]

open access: yesThe Primary Care Companion For CNS Disorders, 2005
To review the current definition of atypicality, discuss the unique features of each atypical antipsychotic, and determine whether the available drugs in this class really meet the classical definition of atypicality.A PubMed search was conducted to identify literature on the subject of this review, supported by additional articles based on the author ...
openaire   +2 more sources

Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects

open access: yesBMC Psychiatry, 2009
Background Although much progress has been made on antipsychotic drug development, precise mechanisms behind the action of typical and atypical antipsychotics are poorly understood.
Song Jonathan   +7 more
doaj   +1 more source

Assessment of Reported Comparative Effectiveness and Safety of Atypical Antipsychotics in the Treatment of Behavioral and Psychological Symptoms of Dementia

open access: yesJAMA Network Open, 2019
Key Points Question Which atypical antipsychotic is most beneficial and safe for the treatment of behavioral and psychological symptoms of dementia? Findings In this network meta-analysis of 17 studies (5373 patients), no significant differences were ...
Ismaeel Yunusa   +4 more
semanticscholar   +1 more source

Atypical antipsychotics in bipolar disorder: systematic review of randomised trials

open access: yesBMC Psychiatry, 2007
Background Atypical antipsychotics are increasingly used for treatment of mental illnesses like schizophrenia and bipolar disorder, and considered to have fewer extrapyramidal effects than older antipsychotics.
Moore R Andrew, Derry Sheena
doaj   +1 more source

Atypical Antipsychotics, Insulin Resistance and Weight; A Meta-Analysis of Healthy Volunteer Studies

open access: yesProgress in Neuro-psychopharmacology and Biological Psychiatry, 2018
&NA; Atypical antipsychotics increase the risk of diabetes and cardiovascular disease through their side effects of insulin resistance and weight gain.
K. Burghardt   +5 more
semanticscholar   +1 more source

Olanzapine-Induced Diabetic Ketoacidosis and Neuroleptic Malignant Syndrome with Rhabdomyolysis: A Case Report [PDF]

open access: yesEndocrinology and Metabolism, 2013
Atypical antipsychotics have replaced conventional antipsychotics in the treatment of schizophrenia because they have less of a propensity to cause undesirable neurologic adverse events including extrapyramidal symptoms, tardive dyskinesia, and ...
Young Kyoung Sa   +9 more
doaj   +1 more source

Drug information update. Atypical antipsychotics and neuroleptic malignant syndrome: nuances and pragmatics of the association

open access: yesBJPsych Bulletin, 2017
Summary Neuroleptic malignant syndrome (NMS) is a rare but potentially fatal adverse event associated with the use of antipsychotics. Although atypical antipsychotics were initially considered to carry no risk of NMS, reports have accumulated over time ...
S. Sarkar, N. Gupta
semanticscholar   +1 more source

Serum paraoxonase levels of schizophrenia patients treated with typical, atypical and combined antipsychotics

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Objective: Schizophrenia is a devastating disorder, starting in early adulthood and continuing with relapses and remissions. Prevalence of schizophrenia is 1% and the life expectancy of these patients is reduced.
Mehmet Akif Camkurt   +6 more
doaj  

Home - About - Disclaimer - Privacy